A routine blood test may pack a bigger punch than previously suspected, suggests a recent analysis of over 3 million Canadian patient records. A finding of thrombocytosis (platelet count >450 x 10 9 ...

We sought to identify changes in platelet (PLT) counts over time, and to evaluate the patterns of thrombocytopenia and thrombocytosis in hospitalized infants 23.8 weeks to term gestation.

A patient who is receiving cisplatin and gemcitabine in 2 cycles for nonsmall-cell lung cancer (NSCLC) developed thrombocytosis (platelet count 800,000/mcL). There are no other side effects. Is it ...

Introduction Lung cancer is the most common cause of cancer‑related death. Accurate and easy‑to‑use prognostic factors are necessary. Increased platelet count might be a potential prognostic factor.

Platelets (also called thrombocytes) are small blood cell fragments made by your bone marrow. They help form blood clots to stop you from bleeding when you've been injured. Platelets are small cell ...

Q: I am a 57-year-old man who thought he was in good health. At my last exam, I had blood drawn. The results show that I have too many platelets, and I have an appointment to see a blood specialist. I ...

Dear Dr. Roach: I am a 60-year-old woman, recently diagnosed with essential thrombocytosis, which apparently is rare and a form of bone marrow cancer. It was found during a routine blood test, and I ...

Thrombocytosis, or raised platelet count, has been recognised as a significant positive predictor for malignancies, especially the LEGO cancers (lung, endometrium, gastric and oesophageal) in the NICE ...

Pediatric and young adult leukemia adoptive therapy (PLAT)-08: A phase 1 study of SC-DARIC33 in pediatric and young adults with relapsed or refractory CD33+ AML. Background: Myelodysplastic ...

NHS Digital will not be amending a QOF Read code which logs patients with thrombocytosis – an elevated platelet count – as having cancer. This comes despite GP users arguing that the code was wrong ...

IMpactMF, randomized, open-label, phase 3 trial of imetelstat (IME) versus best available therapy (BAT) in patients (pts) with intermediate-2 (INT-2) or high-risk (HR) myelofibrosis (MF) relapsed or ...